title: Knowledge Obtained from an Elderly Case of Japanese Encephalitis.
abstract: The nationwide introduction of a Japanese encephalitis (JE) vaccine has contributed to a reduction in the annual infection rate of JE in Japan. However, the current neutralizing antibody prevalence ratio in Japan is approximately 20% in children 3-4 years of age and in people in their forties and fifties. We herein report a man with JE who was definitively diagnosed by multi-virus real-time polymerase chain reaction employing biopsied brain tissue and serological examinations. JE should be kept in mind when a patient has severe encephalitis of unknown etiology. In order to protect the susceptible population from JE, vaccination is recommended, especially for children and middle-aged people.
authors: Department of Pathology & Applied Neurobiology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Japan.
authors: Kyoko
authors: K
authors: Itoh
authors: Kazuhide
authors: K
authors: Iwamoto
authors: Yu
authors: Y
authors: Satoh
authors: Tomoaki
authors: T
authors: Fujita
authors: Kenta
authors: K
authors: Takahashi
authors: Harutaka
authors: H
authors: Katano
authors: Hideki
authors: H
authors: Hasegawa
authors: Tomohiko
authors: T
authors: Takasaki
authors: So
authors: S
authors: Tando
authors: Shinji
authors: S
authors: Fushiki
mesh_terms: D000368:Aged; D000914:Antibodies, Viral / Q000276:immunology; D001706:Biopsy; D004672:Encephalitis, Japanese / Q000175:diagnosis*; D006801:Humans; D007564:Japan; D008297:Male; D060888:Real-Time Polymerase Chain Reaction
chemical_list: D000914:Antibodies, Viral